Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-04-08

Clinical Trial Update: 2-HOBA Phase 2 Clinical Trial in Rheumatoid Arthritis [Phase 2]

View source ↗

Summary

Phase 2 trial of 2-HOBA in rheumatoid arthritis has completed, with results posted on 2026-04-08.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • 2-HOBA (2-HOBA (2-hydroxybenzylamine))

Snippet

Sponsor: Vanderbilt University Medical Center | Conditions: Rheumatoid Arthritis | Phase 2 | Status: COMPLETED | Results posted: 2026-04-08